Latest news with #MariellJessup
Associated Press
02-05-2025
- Health
- Associated Press
Large-scale heart failure initiative boosts use of lifesaving medications
( NewMediaWire ) - May 02, 2025 - DALLAS — About 6.7 million adults in the U.S. are living with heart failure, and that number is expected to increase to more than 8 million by 2030. [1] A new analysis published in Circulation: Heart Failure shows hospitals participating in the American Heart Association's multiregional IMPLEMENT-HF(TM) initiative significantly improved adherence to guideline-directed medical therapy for patients hospitalized with heart failure with reduced ejection fraction (HFrEF), the most common type of heart failure. The American Heart Association, a global force changing the future of health for all, launched the three-year quality improvement initiative in 2021. The goal: improve uptake of quadruple medical therapy and integrate health-related social needs assessments into routine care. Quadruple medical therapy is a combination of four evidence-based drugs proven to reduce mortality: angiotensin receptor–neprilysin inhibitor (ARNI), evidence-based specific β-blocker (BB), mineralocorticoid antagonist (MRA) and sodium-glucose cotransporter 2 inhibitor (SGLT2i). The effort involved more than 100 hospitals across the U.S. and built on the Association's Get With The Guidelines(R) - Heart Failure program. The study included data from more than 43,000 patients at 67 hospitals and found: 'This initiative represents an important leap forward in closing the treatment gap in heart failure,' said Andrew Sauer, M.D., American Heart Association volunteer, a lead author of the research and a cardiologist at Saint Luke's Mid America Heart Institute in Kansas City. 'By supporting collaborative learning and leveraging real-time data, IMPLEMENT-HF enabled hospitals to better serve patients in varied communities.' HFrEF affects nearly half of people hospitalized for heart failure and carries a 75% five-year mortality rate. Although clinical trials have shown that quadruple therapy can significantly improve survival, use of this treatment has remained low nationwide, particularly among underrepresented populations. By creating a structured, 'all-teach, all-learn' environment, the Association's initiative offered participants tools for identifying care gaps, sharing best practices and monitoring performance at both hospital and regional levels. 'The improvements we've seen through IMPLEMENT-HF underscore the power of collaboration,' said Mariell Jessup, M.D., chief science and medical officer of the American Heart Association. 'The Association is committed to transforming systems of care to ensure every person has access to the highest standard of heart failure treatment, no matter where they live.' Additional Resources: ### Statements and conclusions of studies published in the American Heart Association's scientific journals are solely those of the study authors and do not necessarily reflect the Association's policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and biotech companies, device manufacturers and health insurance providers and the Association's overall financial information are available here. About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public's health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on Facebook, X or by calling 1-800-AHA-USA1. For Media Inquiries: 214-706-1173 Michelle Rosenfeld: [email protected] For Public Inquiries: 1-800-AHA-USA1 (242-8721) and [1] Martin S, et al. 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Chapter 22. Circulation. 2025;151(8):e41–e660.
Associated Press
27-01-2025
- Health
- Associated Press
Bridging critical gaps in advanced heart failure care
( NewMediaWire) - January 27, 2025 - DALLAS — About 6.7 million American adults are living with heart failure (HF), and prevalence is expected to reach more than 8 million by 2030. While there is no cure for HF, many people with this condition can live full, enjoyable lives and disease progression can be slowed. While people with early-stage HF often can manage their condition with lifestyle modifications and medications, more advanced therapies may be needed as the disease progresses. Yet, a significant number of patients who may benefit from advanced HF specialty care don't receive it — a gap that particularly affects populations with limited access to health care resources. [2], [3] The American Heart Association, a global force changing the future of health for all, has launched a new $3 million initiative, supported financially by Abbott, that aligns with the rising need for advanced HF treatment pathways and education beyond traditional guideline-directed medical therapy. This effort will provide cardiovascular clinicians with information on care models that connect specialists and clinical teams to improve patient outcomes and support a growing HF population. 'Knowledge gaps among clinicians may contribute to variations and disparities in the types of patients who receive advanced HF therapies, and resultant delays or lack of referral can lead to adverse consequences for patients and their families,' said Mariell Jessup, M.D., FAHA, chief science and medical officer of the American Heart Association. 'This initiative will create nationwide education on the full array of treatment options for eligible people living with advanced heart failure, helping to bridge these gaps.' By engaging 15 carefully selected hospitals across the nation, the American Heart Association's new three-year Heart Failure Education Initiative aims to improve understanding and amplify successful models of HF treatment pathways. Participating sites will: collaborate to share challenges and develop solutions, and have access to education sharing successful models of care through conferences, posters, webinars and more. Multidisciplinary teams at each hospitals will engage in process mapping, expert collaboration and a national roundtable event. The 15 sites include: Allina Health Minneapolis Heart Institute in Minneapolis Avera McKennan Hospital and University Health Center in Sioux Falls, South Dakota Baptist Memorial Hospital Memphis in Memphis, Tennessee East Jefferson General Hospital in Metairie, Louisiana Hackensack University Medical Center in Hackensack, New Jersey JPS Health Network in Fort Worth, Texas Medical University of South Carolina in Charleston, South Carolina Oregon Health and Science University in Portland, Oregon Piedmont Athens Regional Medical Center in Athens, Georgia Saint Luke's Mid America Heart Institute in Kansas City, Missouri The Nebraska Medical Center in Omaha, Nebraska University of California San Diego in La Jolla, California University of Chicago Medicine in Chicago University of Utah Health in Salt Lake City Yale New Haven Hospital in New Haven, Connecticut 'Across the United States, millions of people are living with heart failure, yet far too many of those people see their disease progress while never receiving access to new and innovative treatment approaches and therapy options,' said Keith Boettiger, vice president of Abbott's heart failure business. 'Fostering new connections between primary care physicians, cardiologists and advanced heart failure specialists is critical to ensuring more of these patients can access advanced therapy options that can improve and extend their life.' Learn more about the initiative at Additional Resources: ### About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, we fund groundbreaking research, advocate for the public's health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, we work tirelessly to advance health and transform lives every day. Connect with us on Facebook, X or by calling 1-800-AHA-USA1. For Media Inquiries: 214-706-1173 [1] Chapter 22. 2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation. February 20, 2024. 149(8):e347-e913. [2] Mwansa H, Lewsey S, Mazimba S, et al. Racial/Ethnic and Gender Disparities in Heart Failure with Reduced Ejection Fraction. Curr Heart Fail Rep 2021(18):41–51. [3] White-Williams C, Rossi LP, Bittner VA, Driscoll A, Durant RW, Granger BB, Graven LJ, Kitko L, Newlin K, Shirey M. American Heart Association Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Council on Epidemiology and Prevention. Addressing Social Determinants of Health in the Care of Patients With Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2020 Jun 2;141(22):e841-e863. doi: 10.1161/CIR.0000000000000767.
